...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Ability of Bacteriophage in Resolving Wound Infection Caused by Multidrug-Resistant Acinetobacter baumannii in Uncontrolled Diabetic Rats
【24h】

Ability of Bacteriophage in Resolving Wound Infection Caused by Multidrug-Resistant Acinetobacter baumannii in Uncontrolled Diabetic Rats

机译:噬菌体解决不受控制的糖尿病大鼠多药耐药鲍曼不动杆菌引起的伤口感染的能力

获取原文
获取原文并翻译 | 示例
           

摘要

Acinetobacter baumannii, a substantial nosocomial pathogen, has developed resistance to almost all available antimicrobial drugs. Bacteriophage therapy is a possible alternative treatment for multidrug-resistant (MDR) bacterial infections. In this study, we have successfully isolated bacteriophage active against clinical strains of A. baumannii by enrichment from hospital sewage sludge using representatives of those strains. The bacteriophage isolated against A. baumannii formed plaques against beta-lactamases producing strains of A. baumannii. The utility of bacteriophage specific for A. baumannii to resolve wound infection in uncontrolled diabetic rats was evaluated. Five groups of uncontrolled diabetic rats were used. Group I was noninfected (Control), Group II was infected with MDR A. baumannii and challenged with bacteriophage, Group III was infected with MDR A. baumannii, Group IV was infected with MDR A. baumannii and challenged with antibiotic colistin, and Group V consisted of noninfected rats and sprayed with phage (Phage control). A significant decrease in infection, period of epithelization, and wound contraction was observed in the phage-challenged group when compared with antibiotic-treated uncontrolled diabetic rats and the control group. To conclude the study, new insights are provided into the biology of the broad host range of A. baumannii phage, demonstrating that A. baumannii phage has prospects for the treatment of infections caused by the MDR A. baumannii.
机译:鲍曼不动杆菌是一种重要的医院病原体,已对几乎所有可用的抗菌药物产生耐药性。噬菌体疗法是​​针对多药耐药(MDR)细菌感染的一种可能的替代疗法。在这项研究中,我们已经通过使用这些菌株的代表从医院污水污泥中进行富集,成功分离了对鲍曼不动杆菌临床菌株具有活性的噬菌体。针对鲍曼不动杆菌分离的噬菌体形成针对产生β-内酰胺酶的鲍曼不动杆菌菌株的噬菌斑。评估了鲍曼不动杆菌特有的噬菌体在解决不受控制的糖尿病大鼠中伤口感染中的作用。使用五组不受控制的糖尿病大鼠。第一组是未感染的(对照组),第二组是感染了MDR鲍曼不动杆菌并被噬菌体攻击,第三组是被MDR鲍曼不动杆菌感染,第四组被MDR鲍曼不动杆菌感染并被抗生素杆菌素攻击,第五组由未感染的大鼠组成,并用噬菌体喷雾(噬菌体对照)。与未经抗生素治疗的糖尿病大鼠和对照组相比,噬菌体攻击组的感染率,上皮形成时间和伤口收缩明显减少。结束研究,对鲍曼不动杆菌噬菌体的广泛宿主生物学提供了新的见解,表明鲍曼不动杆菌噬菌体具有治疗由耐多药鲍曼不动杆菌引起的感染的前景。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号